Skip to main content
. 2021 Jul 13;18(14):7486. doi: 10.3390/ijerph18147486

Table 4.

Genotypes and alleles distribution in the case group.

(a) DIAPH2 PTPRD HIC1.
CASE AT AA TT TT AT AA CT TT CC
Smokers 21 – 9,3% 39–17.3% 166–73.4% 114–50.4% 83–36.7% 29–12.9% 104–46.0% 90–39.8% 32–14.2%
Nonsmokers 2–4.9% 10–244.4% 29–70.7% 19–46.3% 20–48.8% 2–4.9% 19–46.3% 17–41.5% 5–12.2%
Drinkers 22–10.7% 36–17.6% 147–71.7% 100–48.8% 78–38.0% 27–13.2% 94–45.8% 85–41.5% 26–12.7%
Nondrinkers 1–1.6% 13–21.3% 47–77.1% 33–54.1% 24–38.3% 4–6.6% 28–45.9% 22–36.1% 11–18.0%
Smokers/Nondrinkers 1–2.2% 8–17.3% 37–80.5% 23–50.0% 19–41.3% 4–8.7% 23–50.0% 15–32.6% 8–17.4%
Nonsmokers/Drinkers 2–7.7% 5–19.2% 19–73.1% 9–34.6% 15–57.7% 2–7.7% 14–53.8% 10–38.5% 2–7.7%
Smokers/Drinkers 20–11.1% 31–17.2% 129–71.7% 91–50.5% 64–35.5% 25–13.0% 81–45.0% 75–41.7% 24–53.3%
Nonsmokers/Nondrinkers 14–28.6% 1–2.0% 34–69.4% 18–36.7% 26–53.1% 5–10.2% 19–38.8% 18–36.7% 12–24.5%
(b) DIAPH2 PTPRD HIC1.
CASE A T ALLELE T A ALLELE C T ALLELE
Smokers 99 353 452-A (0.22:0.78) 311 141 452-A (0.23:0.77) 168 284 452-C (0.36:0.64)
Nonsmokers 22 60 82-A (0.27:0.73) 58 24 82-A (0.29:0.71) 29 53 82-C (0.35:0.65)
Drinkers 94 316 410-A (0.23:0.77) 278 132 410-A (0.32:0.68) 146 264 410-C (0.36:0.64)
Nondrinkers 27 95 122-A (0.22:0.78) 90 32 122-A (0.26:0.74) 50 72 122-C (0.41:0.59)
Smokers/Nondrinkers 17 75 92-A (0.18:0.82) 65 27 92-A (0.29:0.71) 39 53 92-C (0.42:0.58)
Nonsmokers/Drinkers 12 40 52-A (0.23:0.77) 33 19 52-A (0.37:0.63) 18 34 52-C (0.35:0.65)
Smokers/Drinkers 82 278 360-A (0.23:0.77) 246 114 360-A (0.32:0.68) 129 231 360-C (0.36:0,64)
Nonsmokers/Nondrinkers 16 82 98-A (0.16:0.84) 62 36 98-A (0.37:0.63) 43 55 98-C (0.44:0.56)

(a) no statistically significant differences in genotypes distribution of subjects between subgroups of cases. (b) significance difference in DIAPH2 (rs6620138) alleles distribution between subgroups smokers and nonsmokers in the case group (chi- square test—p < 0.005), no other.